Provident Trust Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Provident Trust Company's BMY Position: Q3 2021 in Review
Provident Trust Company sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 6,532 shares — an estimated $436K sold.
Provident Trust Company first reported a position in BMY in Q2 2014 and held it in 29 quarters. The position peaked at $475K in Q2 2016. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.
- Provident Trust Company reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
- Provident Trust Company sold 6,532 Bristol-Myers Squibb shares in Q3 2021, an estimated $436K.
- Provident Trust Company first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 29 quarters.
- Provident Trust Company's Bristol-Myers Squibb position peaked at $475K in Q2 2016.
- 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.
Based on Provident Trust Company's 13F filing for Q3 2021, filed 2 Nov 2021.